Bioanalysis

Papers
(The median citation count of Bioanalysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO39
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population29
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy28
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery24
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar24
Simple Method to Determine the Concentration and Incorporation Ratio of Ruthenium-Labeled Antibodies20
Degradation of Vancomycin in External Quality Assessment Samples is a Factor to Underestimate Its Concentration20
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid19
Adopting ambient ionization mass spectrometry into bioanalytical laboratories16
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox15
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations13
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis13
MS-DIAL pre-processing for mining schistosomiasis metabolites in urine samples from the Okavango Delta of Botswana from a GC-MS dataset13
Patient centric blood sampling and analysis for diagnostics and laboratory medicine13
Selective IgM digestion improves anti-AAV IgG detection in the immune complex assay format12
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics12
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients12
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testing11
Handling Unstable Analytes: Literature Review and Expert Panel Survey by the Japan Bioanalysis Forum Discussion Group11
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference11
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses11
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum11
A clever evaluation of the antidiabetic medications linagliptin and empagliflozin in bulk and spiked urine samples11
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Anahita Keyhani10
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique10
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA10
Comparison of Assay Formats Used for the Detection of Pre-Existing Anti-Drug Antibodies Against Monoclonal Antibodies9
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency9
Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification9
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS9
Bioanalysis Rising Star Award 2024: interviews with the finalists9
Simultaneous Measurement of Mouse and Human Albumin in Chimeric Mice with Humanized Livers8
An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma8
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers8
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System8
A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment8
Special Focus Issue - Covid-19: Bioanalytical Considerations, Contributions and Lessons – Part 28
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma8
Determination of meropenem in capillary plasma microsamples using LC–MS/MS8
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS8
Perspectives on a Flexible Strategy for the Management of Nonregulated Bioanalysis8
Development of a fit-for-purpose semi-homogeneous competitive ELISA for total PEG quantitation in a PEGylated molecule8
Significant matrix effect in fludarabine quantification in plasma: implications for CAR-T cell therapy monitoring8
Highlights of the 13th Japan Bioanalysis Forum Symposium7
Western Blotting: Evolution of an Old Analytical Method To a New Quantitative Tool for Biomarker Measurements7
Critical Reagent Inventory Management System and Web Portal Specifically Optimized for Supporting External Clients7
Highlights of the 15th Japan Bioanalysis Forum Symposium7
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled7
Determination of Amphetamines, Opioids, Cocaine Metabolites and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Using Biocompatible Solid-Phase Microextraction and Ultra-Performance LC–MS/MS7
Development and Validation of qPCR Methods for Nucleic Acid Biomarkers as a Drug Development Tool: Points to Consider7
Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers7
Correction7
Molecularly Imprinted Electrochemical Biosensor for Thrombin Detection by Comparing Different Monomers7
Validation of UV–Vis spectrophotometric colorimetric methods for Rifampicin quantification in PBS & biological matrices7
Special Focus Issue - Performing Flow Cytometry in Clinical Trials6
Novel Isoelectric Target Depletion (ITaD) Protocol Reduces the Need for Specific Reagents for Immunogenicity Testing6
Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations6
High Ionic Strength Dissociation Assay Reduces Dimeric Target Interference in Immunogenicity Testing6
Development and validation of bioanalytical methods to support clinical study of disitamab vedotin6
A Sensitive, Robust and High-Throughput Isotope Dilution LC–MS/MS Method for Quantifying Three Folate Forms in Serum6
An interview with Bioanalysis : speaking with the 2025 international reid bioanalytical forum bursary award winners6
Determination of aloesone in rat plasma by LC–MS/MS spectrometry and its application in a pharmacokinetic study6
Comparison of Requirements for Clinical Study of SARS-CoV-2 Antigen Test Kits in China, the USA and Europe6
Development of an LC-MS/MS assay to analyze a lipid-conjugated siRNA by solid phase extraction (SPE) in mouse plasma and tissue using a stable isotope labeled internal standard (SILIS)6
Upfront Acid Treatment with Low Final pH: The Development and Testing of a Novel Method to Improve Drug Tolerance in Antidrug Antibody Assays6
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics6
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions5
Quantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting5
Effect of Chronopharmacology and Food on in Vivo Pharmacokinetic Profile of Mavacamten5
Revolutionizing depression diagnosis: earwax analysis for cortisol and beyond5
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study5
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates5
Ocular Bioanalysis of Moxifloxacin and Ketorolac Tromethamine in Rabbit Lacrimal Matrix Using Liquid Chromatography–Tandem Mass Spectrometry5
HPLC Method for Simultaneous Estimation of Paclitaxel and Baicalein: Pharmaceutical and Pharmacokinetic Applications5
Greener Bioanalytical Sample Preparation. What is Next?5
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma5
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens5
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats5
Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery5
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma5
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis5
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis5
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications5
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS5
Capillary Electrophoresis Mass Spectrometry for Metabolomics: Reflecting on the Next Steps4
Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints4
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats4
Harmonization of Vaccine Ligand Binding Assays Validation4
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis4
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development4
Bioanalytical tandem mass spectrometry method for cinacalcet in human plasma: green assessment with advanced metrics4
LC-MS/MS method for co-estimation of doxorubicin and piperine: formulation development and pharmacokinetic studies4
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum4
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid4
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective4
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies4
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management4
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents4
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy4
The acute oral toxicity and pharmacokinetic determination of a novel chloroquinoline hybrid molecule by LC-MS/MS4
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling4
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis4
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel4
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides4
High-resolution mass spectrometry for glycoproteomics4
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine4
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu4
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV4
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform4
Detection of Streptococcus anginosus in fecal samples using PCR-CRISPR /Cas12a system4
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control4
Development and validation of highly sensitive ligand binding assay to measure soluble DLL3 concentration in human serum4
High-Throughput MS for Intact Protein Analysis3
Accelerating isotope dilution LC-MS-based desmosine quantification for estimating elastin turnover3
Volumetric absorptive microsampling–LC–MS/MS assays for quantitation of giredestrant in dried human whole blood3
Research progress of N -nitrosamine detection methods: a review3
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bio3
Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum3
Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites3
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population3
Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes3
Bioanalysis Rising Star Award 2023: announcing our finalists3
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency3
Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring3
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?3
Advances in green sample preparation methods for bioanalytical laboratories focusing on drug analysis3
Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography3
Analytical Considerations to Support Expeditious Formulation Development of Vaccines3
Thyroxine Biosensors: A Review on Progress and Challenges3
Testing in the Workplace: Finding a Path Through a Pandemic3
China's NMPA Perspective on the Clinical Performance of SARS-CoV-2 Antigen Test Reagents3
A Validated Capillary Microsampling Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Antisense Oligonucleotides in Mouse Serum3
Simultaneous quantitation of tigecycline, meropenem, polymyxin B in plasma, and protein-binding analysis in HSCT patients3
Nitrosamine Impurities: from Raw Materials to Final Drug Product3
Pharmacokinetics and Toxicity Considerations for Antibody–drug Conjugates: An Overview3
Multi-residue analysis method based on QuEChERS followed by ultra-high performance liquid chromatography coupled with diode-array detector for pesticides in human serum and breast milk3
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables3
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study3
Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment3
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS3
Integrating metering capabilities to increase the utility of self-collected, dried samples3
Comparison of Liquid–Liquid Extraction, Microextraction and Ultrafiltration for Measuring Free Concentrations of Testosterone and Phenytoin3
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; 3
Feasibility of using PALSAR technology as a signal amplifier for antibody bridging assay3
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics3
Welcome to Volume 14 of Bioanalysis3
Large Molecule Bioanalysis by LC–MS: Beyond Simply Quantifying3
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum3
Singlicate analysis in ADA assays: comparing assay performance in duplicate and singlicate formats3
Simultaneous estimation of donepezil and quercetin using ultra high performance liquid chromatography: pharmaceutical and pharmacokinetic applications in Alzheimer’s disease3
Enantioselective electrochemical detection of a L-and D-serine at polyvinylpyrrolidone-modified platinum electrode3
A Bioanalytical Screening Method for Enterococcus faecalis RNPP-type Quorum Sensing Peptides in Murine Feces3
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization3
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription3
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development3
Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories3
Blood Cell Quantification on Dry Blood Samples: Toward Patient-Centric Complete Blood Counts3
Development of a UPLC-MS/MS method for simultaneous quantification of 7 bile acids in feces: application to UC mice3
A Competitive Ligand-Binding Assay to Detect Neutralizing Antibodies to a Bispecific Drug Using a Multiplex Meso Scale Discovery Platform2
A rapid and sensitive UHPLC-MS/MS method for epalrestat detection in micro-volumes of human plasma for the first time2
Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics2
Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically ill children?2
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood2
Analysis of Free Concentrations of Lamotrigine and Active Oxcarbazepine Metabolite in Clinical Patients by Hollow-Fiber Centrifugal Ultrafiltration2
Sensitive LC-MS/MS Quantification of Unconjugated Maytansinoid DM4 and its Metabolite S-methyl-DM4 in Human Plasma2
Highlights of the 14th Japan Bioanalysis Forum Symposium2
Development and Validation of an LC-MS/MS Method for Determination of a Novel Anticancer Agent (CPI-613) in HumanPlasma2
Development and validation of an LC-MS/MS method for the quantification of novel therapeutic TT-478, a selective adenosine receptor 2B antagonist, for a phase I/II clinical trial2
Validated GC-MS methods to detect ethylene, diethylene, and triethylene glycol in serum, plasma, and urine samples2
The Biomarker Bandwagon's Quantitative Quandary: 10 years of Tuning2
Bioanalysis of Six Antibiotics from Volumetric Microsamples: A New Tool for Precision Dosing in Critically ill Children2
Using Innovative Tools for In Vitro Absorption, Distribution, Metabolism and Excretion Studies to Efficiently and Effectively Support Drug Development2
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline2
Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies2
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay2
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena2
Evaluation of singlicate vs duplicate analysis in ligand binding assays: a case study with IFN-γ in mouse and NHP models2
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matrices2
Meet the Editorial Board: An Introduction to and Insights from Fumin Li2
LC–MS/MS Bioanalytical Method for Quantification of Binimetinib and Venetoclax, and their Pharmacokinetic Interaction2
Tuberculosis diagnosis versus GeneXpert ® MTB/RIF formats2
Objective criteria for statistical assessments of cross validation of bioanalytical methods2
Effective Biomarker Measurement is Key for Biotherapeutic Development2
Conference report for the 10th China Bioanalysis Forum annual meeting2
Impact of positive control binding properties on anti-drug antibody assay performance2
Determination of drugs of abuse and metabolites in plasma microsamples by LC-MS/MS after microQuEChERS extraction2
Determination of Levetiracetam by GC-MS and Effects of Storage Conditions and Gastric Digestive Systems on Drug Samples2
European Bioanalysis Forum recommendation on embracing a context-of-use-driven scientific validation for chromatographic assays in the light of ICH M102
Development of a UPLC–MS/MS Method for Determination of a Dual EZH1/2 Inhibitor UNC1999 in Rat Plasma2
Simultaneous Estimation of Raloxifene and Cladrin by HPLC: Application to Metabolic Stability Studies in Different Species2
Latest developments in the detection and quantification of adrenaline: advances and clinical applications2
Stability of Nonsteroidal Anti-Inflammatory Drugs in Urine and Solution: Effects of Degradation on Analytical Assessment2
Immunocapture LC–MS Methods for Pharmacokinetics of Large Molecule Drugs2
The GSK Bioanalytical Hub Model in Bioanalysis: Maximizing the Synergies of Co-Locating Various Platforms in Support of Regulated and Nonregulated Study end Points2
Technique Development of High-Throughput and High-Sensitivity Sample Preparation and Separation for Proteomics2
Considerations for Drug Development Biomarker Assays in the Clinical Laboratory2
Effect of delayed blood centrifugation on cytokine quantitation in serum and plasma2
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective2
Observations from a decade of oligonucleotide bioanalysis by LC-MS2
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment2
Immunoassay Automation is Driving Advancements in Cell and Gene Therapies2
LC-MS/MS Methods to quantify HCP002 in Human Plasma and Urine: Applications in a Pharmacokinetic Study2
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Shefali R Patel2
Evaluation of the light-initiated chemiluminescence assay for quantification of Humulus scandens pollen - specific IgE2
Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study2
16 th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytica2
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device2
Comparison of Pharmacokinetic Profiles in Hypoalbuminemia and Healthy Rats After Parecoxib Sodium Injection by LC–MS/MS2
Feedback from the 10th European Bioanalysis Forum Young Scientist Symposium and from the Science Café discussions on sustainability in bioanalysis2
Quantitative Chromatographic Method Development for Residual Lidocaine in Topical Systems and Biological Samples2
Recommendations on qPCR/ddPCR Assay Validation by GCC2
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices2
WRIB Poster Awards Winners 20242
Navigating IVDR challenges for pharmacokinetic, anti-drug antibodies, and biomarker assays in early clinical research: a recommendation from the European Bioanalysis Forum2
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS2
Development and validation of an LC–MS/MS method to quantify kynurenic acid in human plasma2
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolonga2
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?2
Surrogate Peptide Selection and Internal Standardization for Accurate Quantification of Endogenous Proteins2
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies2
An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma2
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis2
Pharmacokinetic analysis using single dilution assays: enhancing precision, reducing errors and increasing throughput2
Method Development Workflow for Quantifying Protein Biomarkers by Hybrid LC–MS/MS1
Examining hybridization-based LC–MS methodologies for the bioanalysis of siRNA analytes1
Quantitation of Reduced Il-33 Levels in Human Serum: Mitigating Interference From Endogenous Binding Partners1
Multi-Laboratory Evaluation of Immunoaffinity LC–MS-Based Glucagon-Like Peptide-1 Assay1
Bioanalysis of the Bicycle®Toxin Conjugate BT5528 and Released Monomethyl Auristatin E via Liquid Chromatography–Tandem Mass Spectrometry1
The Potential of Oral Fluid in 1Drug Monitoring: An Update1
Ultrasensitive Digital Immunoassays for SOD1 Conformation in Amyotrophic Lateral Sclerosis1
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vacc1
Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence1
Metabolic alterations in the serum of patients with acute ischemic stroke1
Correction1
Bioanalytical LC–MS/MS method for simultaneous estimation of atorvastatin, its major active metabolites and ezetimibe1
Novel Sequential Immunocapture Microflow LC/MS/MS Approach to Measuring PTH-Fc Protein in Human Serum1
Green Sample Preparation in Bioanalysis: Where Are We Now?1
Development of an Immunoassay for Aglycosylated Murine IgG1 in Mouse Serum via Generation of a Specific Tool Antibody1
Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry1
Assessing prognosis by quantifying FcγRIIa on fixed platelets1
WRIB Poster Awards Winners 20231
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patients1
Development and validation of carbodiimide-activated ELISA plate for quantifying IgG levels against Streptococcus pneumoniae capsular polysaccharides1
Development of Fe 3 O 4 /Reduced Graphene Oxide Nanocomposite-Based Dispersive Solid-Phase Extraction for the Quantification of Fi1
An insight into the presence of impurities in reference standards and their impact on mass spectrometry-based bioanalysis1
UHPLC-MS/MS for Plasma Lamotrigine Analysis and Comparison with a Homogenous Enzyme Immunoassay1
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor1
Risk-Based Approach of Bioanalytical Methods for Clinical Immunogenicity Assessment of Multidomain Biotherapeutics1
Determination of drugs of abuse in oral fluid using dried oral fluid spot assisted by 24-well plate and LC–MS/MS1
Monitoring of Hemoglobin and Erythropoiesis-Related mRNA with Dried Blood Spots in Athletes and Patients1
0.067648887634277